GLAXOSMITHKLINE, LLC: $27.3M Department of Health and Human Services Contract
Summary
The Department of Health and Human Services awarded a $27.3M definitive contract to GLAXOSMITHKLINE, LLC for the supply of Relenza (zanamivir) Rotadisk, an influenza antiviral. The contract spans 2025-2028 and supports pandemic preparedness stockpiling. No publicly traded company is directly identified as the recipient, limiting direct market impact.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.The $27.3M contract is small in scale and awarded to a private entity, so no direct public ticker impact.
- 2.Sector-level tailwinds for Healthcare, specifically antiviral stockpiling, remain intact but are not company-specific.
- 3.Investors should monitor broader HHS spending on medical countermeasures for potential future opportunities with public companies.
Market Implications
The contract has negligible immediate market implications given the private recipient and modest size. The broader Healthcare sector continues to see steady demand from government contracts, but this award alone does not alter the competitive landscape. Investors focused on pandemic preparedness should track larger awards to public firms such as GSK (parent of the LLC if matched) or competitors like Roche for Tamiflu.
⚡ Government Convergence
This signal is one of the converging government actions below.
Over the last 90 days, 50 separate government actions have converged on Biodefense / Pandemic Preparedness. What that means: federal dollars are already moving — agencies are soliciting bids and awarding contracts, not just talking, and legislation and executive action are building the policy and funding tailwind behind it. When independent channels move together like this — 41 federal contracts, 5 procurement notices, 3 bills and 1 news — it's the clearest early tell that Washington is committing to biodefense / pandemic preparedness, the kind of build-up that reshapes the sector well before it's obvious in the headlines.
Converging government actions
- Procurement noticeCommissioning Agent Request for Information (RFI) for USAMRIID, Federal Research Laboratory · 2024-10-15
- Procurement noticeProcurement of storage and stability services to maintain BARDA�s supply of Live Attenuated Influenza Virus Master and Working Seed Lots · 2024-10-30
- Procurement noticeNon-Surgical Debridement · 2024-11-12
- Procurement noticeQ301-- Five (5) Full-Time Equivalent Certified Medical Technologists · 2025-03-06
- Procurement noticeIBMSC Resilient Industry and Supply Chain Enterprise (RISE) OTA Consortium · 2025-07-01
- Procurement noticeRFI - Biocontainment, Isolation, and Quarantine (BIQ) Shipboard Isolation System (SIS) · 2025-08-26
- Procurement noticeRelenza (Zanamivir) Rotadisk, 5 mg · 2025-09-05
- Procurement noticeMaintenance Service Plan for Philips Magnetic Resonance 3T Achieva and Philip MR Mid-Tier Power Supply System · 2026-01-15
- Procurement noticeRRPV BoNT-NMJ · 2026-04-20
- ContractEMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.: ACAM2000, SMALLPOX (VACCINIA) VACCINE, LIVE (ACAM) · 2026-06-26
- ContractSIGA TECHNOLOGIES, INC.: PROCUREMENT AND LATE-STAGE DEVELOPMENT OF SMALLPOX ANTIVIRAL DRUG(S) IGF::OT::IGF · 2026-08-24
- ContractFRESENIUS KABI, LLC: $24.4M Department of Health and Human Services Contract · 2026-09-30
- Procurement noticeBARDA Device Development for Scientists Training · 2026-10-02
- ContractFRESENIUS KABI, LLC: $24.4M Department of Health and Human Services Contract · 2026-10-07
Full Analysis
This contract from HHS/ASPR for $27.3M over three years covers the procurement of Relenza (zanamivir), an inhaled antiviral used to treat influenza. The recipient, GLAXOSMITHKLINE, LLC, is a private entity not listed on public exchanges, so the award does not directly affect any specific ticker. However, the contract signals continued government investment in antiviral stockpiles and biodefense, which broadly supports the Healthcare sector, particularly companies involved in infectious disease treatments and pandemic preparedness. Related legislative signals include several maternal health bills, but none have a direct mechanism linking to this antiviral procurement. Supply chain effects are minimal without a publicly traded prime; however, generic manufacturers or raw material suppliers could indirectly benefit. Historically, similar HHS stockpile contracts provide stable but modest revenue streams for private firms, with no outsized market moves for the public sector.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
GLAXOSMITHKLINE, LLC: $18.2M Department of Health and Human Services Contract
GLAXOSMITHKLINE, LLC: $45.5M Department of Health and Human Services Contract
GENENTECH USA, INC: $37.5M Department of Health and Human Services Contract
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Enhancing Program Integrity and Integrity and Interagency Coordination in the Administration of the H-1B Nonimmigrant Visa Program
This executive order directs the Secretaries of State, Labor, and Homeland Security to coordinate with Commerce, Education, and the SBA when processing H-1B petitions, and requires them to consider whether the employer has engaged in layoffs of similarly situated U.S. workers within the past year. It also orders the Labor Department to review past labor condition applications for potential enforcement actions against sponsoring employers, effectively tightening scrutiny on H-1B usage, especially by outsourcing firms.
Accelerating Access To Veterans' Benefits And Employment Opportunities
This proclamation orders the Secretaries of War and Veterans Affairs to mandate rapid, ongoing digital sharing of military personnel and medical records, deploy AI-powered tools for benefits applications, and update existing IT contracts for interoperability. It also requires the Transition Assistance Program to connect separating service members to specific jobs or training programs before discharge.
Delivering Gold Standard Childhood Vaccine Recommendations for Americans
This executive order directs HHS to establish a 'Gold Standard' childhood vaccine schedule with fewer recommended vaccines than current CDC guidelines, mandates that MMR be administered as three separate single-disease shots when domestically available, and instructs the DOJ to challenge state vaccine mandates that do not provide religious or medical exemptions. It also orders HHS to develop alternative adjuvants to aluminum and improve vaccine safety monitoring, while preserving access to existing vaccines.
Contract Details
Recipient
GLAXOSMITHKLINE, LLC
Award Amount
$27,299,970
Awarding Agency
Department of Health and Human Services
Sub-Agency
Office of Assistant Secretary for Preparedness and Response
Contract Type
DEFINITIVE CONTRACT
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →